News | Terumo

August 25, 2016

Financial

Notice Concerning the Determination of Details of Issuance of Stock Options (Share Warrants) (PDF 83.81 KB)

August 04, 2016

Financial

Notice Concerning the Issuance of Stock Options (Share Warrants) (PDF 111.47 KB)

June 24, 2016

Financial

Notice regarding the appointment of Independent Committee Members for the "Policy for Large-scale Acquisitions of Terumo Shares (Takeover Defense Measures" (PDF 104.36 KB)

June 24, 2016

Corporate

Terumo Announces Voting Results for the Election of Directors (PDF 36.14 KB)

June 14, 2016

Corporate

Terumo Acquires Sequent Medical, U.S.-based Developer of New Aneurysm Embolization Device-Accelerating Growth in Neurovascular Treatment-

June 10, 2016

Corporate

FDA Lifts All Remaining Shipping Restrictions at Terumo Cardiovascular Systems' Ann Arbor Facility

June 06, 2016

Corporate

Terumo Launches HeartSheet®: A Global First Cellular and Tissue-based Product Designed for the Treatment of Heart Failure

May 18, 2016

Corporate

Major new study investigating abbreviated DAPT post-stent in high bleeding risk patients announced

Global study involving 4,300 patients from 34 countries announced at EuroPCR

May 10, 2016

Corporate

Terumo Appoints the Candidates for Directors (PDF 35.05 KB)

May 02, 2016

Corporate

Life-Saving Device Brings Eighth Queen's Award

- 1,400 patients' lives saved worldwide thanks to pioneering medical implant -
- Vascutek's device saves hospital providers an estimated £26,000 per operation -

April 18, 2016

Corporate

Terumo Institutes the "Terumo Fellow" Program

March 25, 2016

Financial

Notice Concerning Results and Completion of the Company's Own Shares(Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 14.74 KB)

March 04, 2016

Financial

Notice Concerning the Status of Acquisition of the Company's Own Shares(Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 63.88 KB)

March 04, 2016

Corporate

Terumo's MEDISAFE Fit Smile, a Blood Glucose Meter, Receives an iF Design Award 2016

February 10, 2016

Financial

Notice Concerning Acquisition Results of the Company's Own Shares by ToSTNeT-3 (PDF 17.62 KB)

February 09, 2016

Financial

Notice Concerning Acquisition of the Company's Own Shares through ToSTNeT-3 (PDF 14.04 KB)

February 04, 2016

Financial

Notice Concerning Acquisition of the Company's Own Shares(Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 57.45 KB)

February 04, 2016

Financial

Revision to Full-Year Results Forecast for FY2015 (PDF 49.58 KB)

February 04, 2016

Corporate

Notice Concerning Change of Representative Directors (PDF 97.24 KB)

January 28, 2016

Corporate

Terumo and Quirem Medical Expand Strategic Alliance

November 05, 2015

Financial

Terumo Revises Upward Interim Dividend and Year-End Dividend Forecast for the Fiscal Year Ending March 31, 2016 (PDF 17.28 KB)

September 24, 2015

Financial

Revision to First-Half and Full-Year Results Forecast for FY2015 (PDF 59.8 KB)

September 18, 2015

Corporate

Terumo Receives Approval for the Manufacturer and Sale of its HeartSheet Autologous Skeletal Myoblast Sheets in Japan

September 09, 2015

Corporate

Terumo Invests in Quirem Medical, Focusing on Interventional Oncology Field

September 02, 2015

Corporate

Terumo's Autologous Skeletal Myoblast Sheets Are the First to Be Approved as a Cellular or Tissue-based Products in Japan by a Council of the Ministry of Health, Labour and Welfare

August 12, 2015

Financial

Notice Concerning Acquisition Results of the Company's Own Shares by ToSTNeT-3 (PDF 63.66 KB)

August 11, 2015

Financial

Notice Concerning Acquisition of the Company's Own Shares through ToSTNeT-3 (PDF 21.89 KB)

August 10, 2015

Corporate

Terumo Receives Approval for the Manufacturer and Sale of its Ultimaster Drug-Eluting Coronary Stent in Japan

August 07, 2015

Financial

Notice Concerning the Issuance of Stock Option (Share Warrants) (PDF 84.38 KB)

August 04, 2015

Financial

Notice Concerning Acquisition of the Company's Own Shares(Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 60.58 KB)

June 24, 2015

Financial

Notice regarding the appointment of Independent Committee Members for the "Policy for Large-scale Acquisitions of Terumo Shares (Takeover Defense Measures"

May 28, 2015

Corporate

Terumo to Support Relief Efforts Following Nepal Earthquake

May 19, 2015

Corporate

Terumo Announces CE Mark Clearance for Bioresorbable Scaffold Developed by Arterial Remodeling Technologies (ART)

May 08, 2015

Corporate

Notice Concerning Members of the Board of Directors after the Transition to a Company with an Audit/Supervisory Committee (PDF 56.07 KB)

May 08, 2015

Financial

Notice Regarding Dividend for the Fiscal Year Ended March 31, 2015 (PDF 17.43 KB)

April 23, 2015

Corporate

Notice Concerning Partial Amendment of the Articles of Incorporation (PDF 67.5 KB)

April 23, 2015

Corporate

Notice Concerning Transition to a Company with an Audit/Supervisory Committee (PDF 81.2 KB)

April 17, 2015

Corporate

Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant by U.S. Food & Drug Administration (FDA)

April 10, 2015

Corporate

Daiichi Sankyo and Terumo Announce Application in Japan for Manufacturing and Sales Approval of Intradermal Seasonal Influenza Vaccine

April 06, 2015

Corporate

Terumo and Olympus Expand Interventional System Business Partnership in the U.S. to Cover Urology and Gastroenterology

March 27, 2015

Corporate

FAMHP advises patients to not suspend nor stop any treatments

March 23, 2015

Corporate

Terumo Europe responds to broadcast EenVandaag Injection needles pose no health risks for patients

February 12, 2015

Corporate

Terumo Establishes a New R&D Center for Interventional Business in Southern California, US to Accelerate Worldwide Growth of Interventional Therapeutic Area

February 03, 2015

Financial

Notice Concerning Acquisition of the Company's Own Shares (Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 73.77 KB)

December 25, 2014

Corporate

Terumo Commences Sales of Tercross® PTA Balloon Catheters in Europe

Designed for a Wide Range of Treatments for Small Peripheral Blood Vessels Including Ones Below The Knee

December 15, 2014

Corporate

Government of Ghana Endorses Collaboration to Combat Ebola Epidemic Page Content

AABB, Global Blood Fund and Terumo BCT commit resources to Ghanaian Ebola Readiness and Resilience Initiative

December 04, 2014

Corporate

Terumo receives CE Mark approval for the line extension on Drug-eluting Stent, Ultimaster® to advance the treatment of coronary artery disease

October 31, 2014

Corporate

Terumo Announces its Application for the Manufacture and Sales Approval of its Skeletal Myoblast Sheets - To Aim for the World's First Cardiac Regenerative Therapy

October 23, 2014

Corporate

Terumo transforms product portfolio of Hospital and Laboratory Business in Europe (PDF 177.35 KB)

September 23, 2014

Corporate

Terumo Cardiovascular Group to Distribute Nonin Medical’s SenSmart™ Model X-100 Universal Oximetry System in U.S. Cardiovascular Hospitals